Genomic Health, Inc.
GHDX
GHDX was delisted on the 7th of November, 2019.
117 hedge funds and large institutions have $644M invested in Genomic Health, Inc. in 2015 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 36 reducing their positions, and 16 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 36
2% more call options, than puts
Call options by funds: $939K | Put options by funds: $919K
4% less funds holding
Funds holding: 122 → 117 (-5)
22% less capital invested
Capital invested by funds: $826M → $644M (-$182M)
25% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 16
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$14.3M |
| 2 |
DCM
Decade Capital Management
New York
|
+$10.8M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$9.02M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$2.09M |
| 5 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
+$1.99M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$4.39M |
| 2 |
Goldman Sachs
New York
|
-$4.02M |
| 3 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$3.64M |
| 4 |
DM
Deerfield Management
New York
|
-$2.31M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$1.69M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AAM
126
Azzad Asset Management
Falls Church,
Virginia
| – | -$230K | -8,258 | Closed |
|
127
KBC Group
Brussels,
Belgium
| – | -$204K | -7,336 | Closed |
|
|
ECM
128
EagleClaw Capital Management
Boston,
Massachusetts
| – | -$203K | -7,300 | Closed |
|
|
SKK
129
Shepherd Kaplan Krochuk
Boston,
Massachusetts
| – | -$202K | -7,258 | Closed |
|
130
Invesco
Atlanta,
Georgia
| – | -$126K | -4,534 | Closed |
|
131
Group One Trading
Chicago,
Illinois
| – | -$24.9K | -965 | Closed |
|
132
US Bancorp
Minneapolis,
Minnesota
| – | -$14K | -503 | Closed |
|
|
FMA
133
FNY Managed Accounts
New York
| – | -$2.78K | -100 | Closed |
|
GHDX Hedge Fund Activity: Q3 2015 in Review
117 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q3 2015, worth a combined $644M — down 22% from $826M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of GHDX and 12 opened new positions — a net loss of 4 holders — while 36 trimmed existing stakes and 48 added.
The largest buyer was Millennium Management, adding an estimated $14.3M. The largest seller was JP Morgan Chase, cutting an estimated $4.39M.
- 117 institutional investors held Genomic Health, Inc. (GHDX) as of Q3 2015, down from 122 in Q2 2015.
- Funds reported $644M of Genomic Health, Inc. stock for Q3 2015, down 22% quarter-over-quarter.
- 12 funds opened new Genomic Health, Inc. positions in Q3 2015 and 16 closed out, a net change of -4 holders.
- The largest Genomic Health, Inc. buyer in Q3 2015 was Millennium Management, an estimated $14.3M added.
- The largest Genomic Health, Inc. seller in Q3 2015 was JP Morgan Chase, an estimated $4.39M sold.
Based on aggregated 13F filings for Q3 2015.